Earnings Hints & Reports — November 03, 2026 — Midday Update — Last 20 Hours (Pacific Time)

Executive Summary

The Q3 2026 earnings season is running broadly constructive, with the majority of reporting companies delivering beats on EPS — though revenue misses are a recurring theme, suggesting top-line growth remains uneven. Stock reactions have been notably punishing for guidance disappointments (Dynatrace -16%, Zebra Technologies -8%, Shopify -10%, TeamViewer -19%), even when current-quarter results beat estimates, signaling that investors are laser-focused on forward outlooks. Key themes include AI infrastructure demand driving semiconductor and networking beats, margin pressure across consumer and industrial names, and a bifurcated energy sector where refiners outperform while some E&P names struggle.

Earnings Performance Breakdown

Classification sample of key reports:

Notable Earnings Reports

🟢 Madrigal Pharmaceuticals (MDGL) — Massive Beat

• EPS of $1.83, beat by $2.66 vs. estimate of -$0.83; revenue also topped estimates
• Stock surged ~10%
• Strong Rezdiffra sales drove the swing to profitability ahead of schedule

🟢 Gartner (IT) — Strong Beat

• EPS of $3.59, beat by $0.75; revenue also topped estimates
• One of the largest EPS surprise magnitudes among large-cap reporters this cycle
• Research and advisory demand remains robust

🟢 Allison Transmission (ALSN) — Beat + Raised Guidance

• EPS of $2.90, beat by $0.58; revenue topped estimates
• Stock soared on results
• Raised full-year guidance signals sustained demand strength

🟢 Neurocrine Biosciences (NBIX) — Large Beat

• EPS of $3.29, beat by $1.38; revenue topped estimates
• One of the largest EPS beats in the biotech space this period
• No specific stock reaction mentioned, but magnitude of beat is notable

🔴 Adeia (ADEA) — Miss + Guidance Cut

• EPS of $0.21, missed by $0.14; revenue also fell short
• Stock plummeted ~24% in after-hours trading
• Weak guidance compounded the earnings miss for the IP licensing company

🔴 Apollo Global Management (APO) — Double Miss

• EPS of $2.07, missed by $0.15; revenue also fell short of estimates
• No specific stock reaction stated
• Rare stumble for the alternative asset manager in an otherwise strong financial sector

🟢 Grab Holdings — Beat + Raised Outlook

• Raised full-year revenue and earnings outlook
• Stock surged ~10% in premarket
• Southeast Asia super-app demonstrating accelerating profitability trajectory

🔴 Shopify (SHOP) — GMV Miss Triggers Selloff

• EPS beat by $0.02; revenue in-line — but Q3 GMV and subscription revenue missed estimates
• Stock fell ~10% in early U.S. trading
• Investors focused on the GMV shortfall as a leading indicator of merchant activity

🟢 Ferrari (RACE) — Beat + Guidance Upgrade

• EPS of $2.78, beat by $0.46; revenue topped estimates
• Stock rose more than 1%
• Raised 2026 guidance; Q3 profit beat driven by strong pricing power

🔴 Dynatrace (DT) — Beat But Guidance Disappoints

• EPS of $0.54, beat by $0.05; revenue topped estimates
• Stock tumbled ~16% on disappointing forward guidance
• Classic "sell the guidance" reaction in a high-multiple software name

Sector Analysis

🟢 Technology / Semiconductors — Broadly Strong
Multiple chip and tech names beat: ON Semiconductor (+$0.03), Lattice Semiconductor (strong FPGA demand), Fabrinet (+$0.15 with robust guidance), Aehr Test Systems (+$0.18, soared 15%). AI-driven demand for semiconductors and optical components is a consistent tailwind. However, guidance-driven selloffs in Dynatrace (-16%) and Zebra Technologies (-8%) show the bar is high for software/enterprise tech.

🟢 Energy / Refining — Refiners Outperform
Marathon Petroleum beat by $1.55, CVR Energy beat by $1.59 — both with revenue beats. MPLX raised its distribution 12.5%. Energy Transfer raised guidance despite a slight EPS miss. Refiners are the clear standout; E&P names more mixed (Valaris missed by $0.47, Ardmore Shipping missed by $0.30).

🟢 Industrials — Solid Across the Board
Eaton, Ametek, Regal Rexnord (data center sales surge), Allison Transmission, Revvity, Louisiana-Pacific, and Ball Corporation all beat. Industrial demand — particularly tied to data centers and power infrastructure — is a recurring theme.

🟢 Pharma / Biotech — More Beats Than Misses
Pfizer beat and raised annual profit forecast; BioNTech beat by €0.98 and raised 2026 revenue guidance; Madrigal surged 10%; Neurocrine beat by $1.38; Teva beat by $0.14; Amneal beat and raised guidance. Travere Therapeutics and Emergent BioSolutions were notable misses.

🔴 Consumer / Retail — Uneven
Shopify -10% on GMV miss; Yum! Brands beat EPS but missed revenue; Yum China beat profit but missed revenue (-4% stock reaction); Luckin Coffee missed revenue estimates; Vital Farms missed both; Knife River missed and guided weak (-3%). Consumer spending softness is visible at the top line even when cost management holds EPS up.

🔴 European Names — Mixed with Notable Warnings
TeamViewer crashed 19% on a 2026 revenue outlook cut; Hugo Boss cut its 2026 outlook on weak demand and higher costs; Zalando fell 5% on margin miss despite a sales beat; Coloplast fell on EBIT miss. Bayer (+5%) and Lufthansa (+3%) were bright spots.

🟡 Financial Services — Mostly In-Line
Fiserv beat slightly; Voya Financial in-line; Apollo missed; Equitable Holdings beat; Corebridge missed narrowly. The sector is performing but not generating outsized surprises.

Biggest Movers

Biggest Upside Reactions:

• 🟢 Grab — +~10% premarket (raised full-year outlook)
• 🟢 Madrigal Pharmaceuticals — +~10% (massive EPS beat, Rezdiffra strength)
• 🟢 Harmonic — +~17% (raised annual outlook despite slight EPS miss)
• 🟢 Aehr Test Systems — +~15% (beat + raised guidance)
• 🟢 Upwork — +~10.5% (earnings beat + solid guidance)
• 🟢 Eurocash — +~12% (Q3 profit more than doubled)
• 🟢 BioMérieux — +~4% (organic sales beat)
• 🟢 Bayer — +~5% (raised 2026 earnings and cash flow outlook)
• 🟢 Revvity — +~5% (beat + raised guidance)
• 🟢 Louisiana-Pacific — +~5% (Q3 beat)
• 🟢 Regal Rexnord — +~3% (data center sales surge)
• 🟢 Talen Energy — +~3% (beat + strong guidance)
• 🟢 Lufthansa — +~3% (Q3 profit beat)

Biggest Downside Reactions:

• 🔴 Adeia — -~24% after-hours (miss + weak guidance)
• 🔴 TeamViewer — -~19% (2026 revenue outlook cut)
• 🔴 Dynatrace — -~16% (disappointing guidance despite beat)
• 🔴 Truecaller — -~16% (Q3 loss + user growth warning)
• 🔴 Shopify — -~10% (GMV + subscription revenue miss)
• 🔴 Zebra Technologies — -~8% (weak Q4 guidance despite Q3 beat)
• 🔴 DigitalOcean — -~8% (fell despite beat and raised guidance — valuation concern)
• 🔴 Clarivate — -~6% (revenue miss despite EPS beat)
• 🔴 JBT Marel — -~6% (revenue miss despite EPS beat)
• 🔴 Zalando — -~5% (margin miss outweighed sales beat)
• 🔴 Yum China — -~4% (revenue miss despite profit beat)
• 🔴 Apple — -~3% (guidance for tightening margins, slowing services growth)
• 🔴 Palantir — -~5% (soft indicator despite strong U.S. commercial sales)

Largest EPS Surprises (Magnitude):

• 🟢 Jazz Pharmaceuticals: missed by $10.18 (largest absolute miss — likely one-time item)
• 🟢 Madrigal: beat by $2.66
• 🟢 Neurocrine: beat by $1.38
• 🟢 Centerspace: beat by $7.13 (likely asset sale or one-time gain)
• 🔴 Pampa Energia: missed by $2.40
• 🔴 Adapthealth: missed by $1.20
• 🔴 Willis Lease: missed by $1.06

Market Implications

The dominant narrative from this earnings wave is a beat-on-EPS, miss-on-revenue pattern, which reflects companies successfully managing costs and margins even as top-line growth moderates. This is a late-cycle characteristic — businesses are leaner, but organic demand is not accelerating uniformly. Investors are rewarding operational discipline but punishing any hint of forward deceleration, as seen in the violent reactions to guidance cuts at Dynatrace, Zebra Technologies, and TeamViewer.

AI-adjacent infrastructure remains the most reliable growth pocket. Semiconductor names (ON Semi, Lattice, Fabrinet, Aehr Test), industrial power plays (Eaton, Regal Rexnord), and networking companies continue to benefit from data center buildout. The upcoming reports from Arista Networks, Datadog, and Astera Labs will be critical tests of whether this AI capex cycle is broadening or narrowing.

Consumer and European discretionary are flashing caution. Shopify's GMV miss, Luckin Coffee's revenue shortfall, Hugo Boss's outlook cut, and Zalando's margin compression all point to a consumer that is spending more selectively. Meanwhile, the guidance-heavy selloffs — even in companies that beat current-quarter numbers — suggest the market is pricing in a more challenging 2027 environment and leaving little room for error.

Key Takeaways

• 🔴 Adeia (ADEA) — Stock crashed ~24% after-hours; miss + weak guidance is a brutal combination for an IP licensing company with limited near-term catalysts
• 🟢 Madrigal Pharmaceuticals (MDGL) — Rezdiffra is delivering; a $2.66 EPS beat and 10% stock surge validate the NASH drug's commercial launch trajectory
• 🔴 Shopify (SHOP) — GMV miss matters more than EPS; the -10% reaction signals investors view merchant volume as the true health metric for this platform
• 🔴 Dynatrace (DT) / Zebra Tech (ZBRA) — Guidance cuts punished even when Q3 beat; high-multiple tech names have zero tolerance for forward deceleration in this market
• 🟢 Allison Transmission (ALSN) — Beat + raised guidance = stock soared; industrial names tied to defense and commercial vehicles are holding up well
• 🟢 Grab Holdings — +10% on raised full-year outlook; Southeast Asia's super-app is proving the profitability skeptics wrong
• 🟢 Refiners outperforming — Marathon Petroleum (+$1.55 beat), CVR Energy (+$1.59 beat); crack spreads and operational efficiency are rewarding refining-heavy energy names
• 🔴 Apple (AAPL) — Beat the quarter but fell ~3% on margin tightening and slowing services growth; services deceleration is a key risk to watch into 2027
• 🟢 Pfizer (PFE) — Beat by $0.14 and raised annual profit forecast; blood thinner demand is providing a stable revenue floor post-COVID product normalization
• 🔴 TeamViewer — -19% on 2026 revenue outlook cut; slower enterprise deal closures are a warning sign for B2B SaaS broadly
• 🟢 BioNTech (BNTX) — Beat by €0.98 and raised 2026 revenue guidance; the post-COVID pivot is gaining traction
• 🟡 Palantir — Despite strong U.S. commercial AI sales, stock fell ~5%; a "soft indicator" in the report spooked momentum investors
• 🟢 Neurocrine (NBIX) — Beat by $1.38; one of the largest biotech EPS surprises of the cycle — watch for analyst estimate revisions higher
• 🔴 Apollo Global (APO) — Rare double miss for the alternative asset manager; worth monitoring whether this is a one-quarter blip or signals fee revenue pressure
• 🟢 Eaton (ETN) — Beat + strong demand; power infrastructure and data center exposure continues to be a reliable growth driver for industrials
• 🟢 Fabrinet (FN) — Beat + robust Q2 guidance; optical interconnect demand for AI data centers is accelerating, not slowing
• 🔴 Hugo Boss / Zalando — European luxury and fashion are under pressure from weak demand and margin compression; a cautionary read for global consumer discretionary
• 🟢 Aehr Test Systems (AEHR) — +15% on beat + raised guidance; a small-cap semiconductor equipment name benefiting from power device testing demand
• 🟡 DigitalOcean (DOCN) — Fell 8% despite beating and raising guidance; valuation sensitivity is extreme for cloud infrastructure names outside the hyperscaler tier
• 🟢 Upwork (UPWK) — +10.5% on beat + solid guidance; freelance platform demand is recovering, a positive read for the gig economy

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/